Review of the Effects of Anti-Angiogenic Compounds on the Epiphyseal Growth Plate

The formation of new blood vessels from a pre-existing vascular bed, termed “angiogenesis,” is of critical importance for the growth and development of the animal since it is required for the growth of the skeleton during endochondral ossification, development and cycling of the corpus luteum and ut...

Full description

Saved in:
Bibliographic Details
Published in:Toxicologic pathology 2006-01, Vol.34 (2), p.131-147
Main Authors: Hall, Anthony P., Westwood, F. Russell, Wadsworth, Peter F.
Format: Article
Language:English
Subjects:
Angiogenesis Inhibitors - pharmacology
Angiopoietins - physiology
Animals
Extracellular Matrix - physiology
Growth Plate - blood supply
Growth Plate - cytology
Growth Plate - drug effects
Humans
Neovascularization, Physiologic - drug effects
Neovascularization, Physiologic - physiology
Osteogenesis - drug effects
Pericytes - physiology
Proto-Oncogene Proteins pp60(c-src) - antagonists & inhibitors
Proto-Oncogene Proteins pp60(c-src) - physiology
Rats
Rats, Sprague-Dawley
Receptors, Vascular Endothelial Growth Factor - physiology
Vascular Endothelial Growth Factor A - physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The formation of new blood vessels from a pre-existing vascular bed, termed “angiogenesis,” is of critical importance for the growth and development of the animal since it is required for the growth of the skeleton during endochondral ossification, development and cycling of the corpus luteum and uterus, and for the repair of tissues during wound healing. “Vasculogenesis,” the de novo formation of blood vessels is also important for the proper function and development of the vascular system in the embryo. New blood vessel formation is a prominent feature and permissive factor in the relentless progression of many human diseases, one of the most important examples of which is neoplasia. It is for this reason that angiogenesis is considered to be one of the hallmarks of cancer. The development of new classes of drugs that inhibit the growth and proper functioning of new blood vessels in vivo is likely to provide significant therapeutic benefit in the treatment of cancer, as well as other conditions where angiogenesis is a strong driver to the disease process. During the preclinical safety testing of these drugs, it is becoming increasingly clear that their in vivo efficacy is reflected in the profile of “expected toxicity” (resulting from pharmacology) observed in laboratory animals, so much so, that this profile of “desired” toxicity may act as a signature for their anti-angiogenic effect. In this article we review the major mechanisms controlling angiogenesis and its role during endochondral ossification. We also review the effects of perturbation of endochondral ossification through four mechanisms—inhibition of vascular endothelial growth factor (VEGF), pp60 c-Src kinase and matrix metalloproteinases as well as disruption of the blood supply with vascular targeting agents. Inhibition through each of these mechanisms appears to have broadly similar effects on the epiphyseal growth plate characterised by thickening due to the retention of hypertrophic chondrocytes resulting from the inhibition of angiogenesis. In contrast, in the metaphysis there are differing effects reflecting the specific role of these targets at this site.
ISSN:0192-6233
1533-1601
DOI:10.1080/01926230600611836